ADMA Biologics, Inc

(NASDAQ:ADMA)

Latest On ADMA Biologics, Inc (ADMA):

Date/Time Type Description Signal Details
2023-05-11 01:31 ESTNewsADMA Biologics GAAP EPS of -$0.03 beats by $0.01, revenue of $57M beats by $3.59MN/A
2023-05-11 01:30 ESTNewsADMA Biologics, Inc. (ADMA) Q1 2023 Earnings Call TranscriptN/A
2023-05-09 23:31 ESTNewsADMA Biologics Q1 2023 Earnings PreviewN/A
2023-03-30 00:16 ESTNewsADMA Biologics: Growth Trends Pointing To ProfitabilityN/A
2023-03-24 06:16 ESTNewsADMA Biologics GAAP EPS of -$0.06 beats by $0.01, revenue of $49.95M beats by $1.88MN/A
2023-03-24 06:16 ESTNewsADMA Biologics expects first-time positive EBITDA by second half of yearN/A
2023-03-24 06:15 ESTNewsADMA Biologics, Inc. (ADMA) Q4 2022 Earnings Call TranscriptN/A
2023-03-22 23:00 ESTNewsADMA Biologics Q4 2022 Earnings PreviewN/A
2023-02-08 18:02 ESTNewsADMA Biocenters receives FDA approval for eighth plasma collection centerN/A
2023-01-17 17:02 ESTNewsADMA Biologics gains as guidance exceeds consensusN/A
2023-01-15 06:00 ESTNewsADMA Biologics: FY22 Numbers Key Inflection PointN/A
2022-12-13 19:01 ESTNewsAdma gets FDA approval for room temperature storage of Asceniv, BivigamN/A
2022-12-08 03:17 ESTNewsADMA Biologics stock dips after pricing ~$60M share offeringN/A
2022-12-07 07:16 ESTNewsADMA Biologics down 7% following stock offeringN/A
2022-11-11 05:31 ESTNewsADMA Biologics hits 52-week high after strong Q3 beatN/A
2022-11-09 19:31 ESTNewsADMA Biologics GAAP EPS of -$0.08 in-line, revenue of $41.09M beats by $6.61MN/A
2022-11-09 19:30 ESTNewsADMA Biologics, Inc. (ADMA) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 01:31 ESTNewsADMA Biologics Q3 2022 Earnings PreviewN/A
2022-10-31 13:46 ESTNewsAdma stock rises on FDA approval of North Carolina-based plasma collection centerN/A
2022-10-24 18:01 ESTNewsAdma Biologics: Understanding The Risks Of Blood Plasma CollectionN/A
2022-08-22 16:50 ESTNewsADMA Biologics: Strong Growth Is Clearing The Path To ProfitabilityN/A
2022-08-11 22:17 ESTNewsADMA Biologics, Inc.'s (ADMA) CEO Adam Grossman on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 22:16 ESTNewsAdma stock rises 10% after Q2 revenue nearly doubles, net loss narrowsN/A
2022-08-11 05:31 ESTNewsADMA Biologics GAAP EPS of -$0.07, revenue of $33.9MN/A
2022-08-11 05:30 ESTNewsADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 17:45 ESTNewsADMA Biologics Q2 2022 Earnings PreviewN/A
2022-06-27 23:02 ESTNewsADMA's 6th plasma collection facility gets FDA approvalN/A
2022-06-21 22:02 ESTNewsADMA biologics to enter Russell 2000 indexN/A
2022-05-13 06:31 ESTNewsADMA Biologics: A Path To Profits Looks ClearN/A
2022-05-12 11:47 ESTNewsADMA Biologics, Inc.'s (ADMA) CEO Adam Grossman on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-11 18:00 ESTNewsADMA Biologics GAAP EPS of -$0.13 misses by $0.04, revenue of $29.1M beats by $0.95MN/A
2022-05-11 18:00 ESTNewsADMA Biologics up 4% after increasing 2022 revenue guidanceN/A
2022-05-10 22:45 ESTNewsADMA Biologics Q1 2022 Earnings PreviewN/A
2022-04-19 02:16 ESTNewsADMA: Pertinent UpdatesN/A
2022-04-04 13:21 ESTNewsADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-29 21:17 ESTNewsADMA Biologics' 2021 Numbers Showed Continued Strong ExecutionN/A
2022-03-25 12:19 ESTNewsADMA Biologics GAAP EPS of -$0.09 beats by $0.01, revenue of $26.38M beats by $4.61MN/A
2022-03-25 12:19 ESTNewsADMA Biologics up in after-hours trading following quarterly top and bottom line beatsN/A
2022-03-25 12:18 ESTNewsADMA Biologics gets FDA approval to extend shelf life of Asceniv, BivigamN/A
2022-03-24 02:33 ESTNewsADMA Biologics Q4 2021 Earnings PreviewN/A
2022-02-10 22:16 ESTNewsAdma Biologics activist said to support strategic reviewN/A
2022-01-19 08:15 ESTNewsADMA biologics expects record preliminary 4Q and FY21 revenues to be above the consensusN/A
2022-01-18 16:46 ESTNewsADMA Biologics wins FDA nod for its fourth plasma collection centerN/A
2022-01-18 16:46 ESTNewsADMA Biologics: 2021 Was ToughN/A
2021-12-28 22:16 ESTNewsFDA updates EUA for COVID convalescent plasma limiting use to certain patientsN/A
2021-12-09 15:17 ESTNewsADMA Biologics secures new European patent related to S. pneumonia infectionsN/A
2021-11-20 23:16 ESTNewsADMA Biologics: Turning A CornerN/A
2021-11-11 20:31 ESTNewsADMA Biologics raised to Strong Buy at Raymond James citing financial momentumN/A
2021-11-11 00:15 ESTNewsADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-10 01:31 ESTNewsADMA Biologics Q3 2021 Earnings PreviewN/A

About ADMA Biologics, Inc (ADMA):

ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.

See Advanced Chart

General

  • Name ADMA Biologics, Inc
  • Symbol ADMA
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 313
  • Fiscal Year EndDecember
  • IPO Date2013-10-17
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.admabiologics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 5.32
  • Price/Book (Most Recent Quarter) 3.7
  • Enterprise Value Revenue 7.55
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.17
  • Profit Margin -166%
  • Operating Margin -138%
  • Return on Assets -21%
  • Return on Equity -124%
  • Revenue 40.3 million
  • Earnings Per Share -$1.24
  • Revenue Per Share $0.53
  • Gross Profit -10155155
  • Quarterly Earnings Growth 42.3%
View More

Highlights

  • Market Capitalization 195.71 million
  • EBITDA -52103768
  • Analyst Target Price $8.83
  • Book Value Per Share $0.80
View More

Share Statistics

  • Shares Outstanding 94.55 million
  • Shares Float 76.07 million
  • % Held by Insiders 213%
  • % Held by Institutions 54.51%
  • Shares Short 8.18 million
  • Shares Short Prior Month 8.75 million
  • Short Ratio 1.91
  • Short % of Float 12%
  • Short % of Shares Outstanding 9%
View More

Technicals

  • Beta 1.7
  • 52 Week High $4.2
  • 52 Week Low $1.73
  • 50 Day Moving Average 2.42
  • 200 Day Moving Average 2.23
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

ADMA Biologics, Inc (ADMA) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

ADMA Biologics, Inc (ADMA) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-05$N/A-$0.19-$0.204.04%
2020-06-302020-08-05$N/A-$0.23-$0.16-42.24%
2020-03-312020-05-06$N/A-$0.26-$0.11-128.07%
2019-12-312020-03-12$12.04 million-$0.18-$0.18-0.95%
2019-09-302019-11-06$7.22 million-$0.19-$0.2315.56%
2019-06-302019-08-08$6.56 million-$0.25-$0.2914.65%
2019-03-312019-05-08$3.53 million-$0.28-$0.3211.39%
2018-12-312019-03-13$4.06 million-$0.39-$0.33-17.15%
2018-09-302018-11-08$4.23 million-$0.33-$0.31-6.45%
2018-06-302018-08-10$4.66 million-$0.35-$0.31-11.86%
2018-03-312018-05-14$4.04 million-$0.39-$0.31-26.83%
2017-12-312018-03-05$12 million-$0.24-$0.3938.46%
2017-09-302017-11-03$4.73 million-$0.59-$0.50-18.59%
2017-06-302017-08-11$3.4 million-$0.55-$0.30-84.87%
2017-03-312017-05-12$2.63 million-$0.51-$0.28-80.53%
2016-12-312017-02-24$3.33 million-$0.34-$0.32-5.59%
2016-09-302016-11-10$2.94 million-$0.34-$0.4117.87%
2016-06-302016-08-12$2.27 million-$0.50-$0.38-30.89%
2016-03-312016-05-13$2.12 million-$0.43-$0.442.82%
2015-12-312016-03-23$2.51 million-$0.44-$0.452.22%
2015-09-302015-11-10$1.85 million-$0.48-$0.39-23.08%
2015-06-302015-08-11$1.31 million-$0.44-$0.35-25.71%
2015-03-312015-05-12$1.5 million-$0.37-$0.382.63%
2014-12-312015-03-09$1.49 million-$0.38-$0.380%
2014-09-302014-11-10$1.37 million-$0.36-$0.372.7%
2014-06-302014-08-11$1.5 million-$0.43-$0.5217.31%
2014-03-312014-05-12$1.56 million-$0.64-$0.49-30.61%
2013-12-312014-03-28$425000-$0.54-$0.47-14.89%
2013-09-302013-11-12$1.11 million-$0.29

ADMA Biologics, Inc (ADMA) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

ADMA Biologics, Inc (ADMA) Chart:

ADMA Biologics, Inc (ADMA) News:

Below you will find a list of latest news for ADMA Biologics, Inc (ADMA) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

ADMA Biologics, Inc (ADMA) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-09-19100CALL0 0426.76TRUE00
2025-09-19117.1CALL0 3216.73TRUE00
2025-09-19125.6CALL0 80TRUE00
2025-09-19134.41CALL0 130TRUE00
2025-09-19142.1CALL0 1081TRUE00
2025-09-19151.3CALL0 3467.85TRUE00
2025-09-19160.1CALL54 11752FALSE-0.25-0.71
2025-09-19170.03CALL64 39265.37FALSE-0.12-0.8
2025-09-19180.09CALL3 1405117.69FALSE0.090
2025-09-19190.03CALL13 518115.25FALSE0.030
2025-09-19200.02CALL0 845173.95FALSE00
2025-09-19210.05CALL0 184171.19FALSE00
2025-09-19220.05CALL0 182190.74FALSE00
2025-09-19230.32CALL0 63414.42FALSE00
2025-09-19240.05CALL0 42438.72FALSE00
2025-09-19250.01CALL0 17379.42FALSE00
2025-09-19260CALL0 0735.93FALSE00
2025-09-19270CALL0 0758.47FALSE00
2025-09-19280CALL0 0746.42FALSE00
2025-09-19290CALL0 0791.67FALSE00
2025-09-19300CALL0 0810.84FALSE00
2025-09-19310CALL0 0617.69FALSE00
2025-09-19320CALL0 0713.54FALSE00
2025-09-19350CALL0 0894.61FALSE00
2025-09-19100PUT0 0815.93FALSE00
2025-09-19110.01PUT0 4423.56FALSE00
2025-09-19120.12PUT0 1192.41FALSE00
2025-09-19130.08PUT0 43281.48FALSE00
2025-09-19140.08PUT0 170567.17FALSE00
2025-09-19150.2PUT33 226752.32FALSE0.20
2025-09-19160.6PUT21 166041.87TRUE0.230.62
2025-09-19171.5PUT11 1860TRUE0.60.67
2025-09-19182.22PUT2 4361.69TRUE-0.03-0.01
2025-09-19193.19PUT0 30TRUE00
2025-09-19203.5PUT0 096.29TRUE00
2025-09-19210PUT0 0263.65TRUE00
2025-09-19222.83PUT0 0348.66TRUE00
2025-09-19236.5PUT0 0281.1TRUE00
2025-09-19240PUT0 0301.65TRUE00
2025-09-19250PUT0 0394.86TRUE00
2025-09-19260PUT0 0356.83TRUE00
2025-09-19270PUT0 0434.04TRUE00
2025-09-19280PUT0 0372.85TRUE00
2025-09-19290PUT0 0440.36TRUE00
2025-09-19300PUT0 0499.13TRUE00
2025-09-19310PUT0 0501.16TRUE00
2025-09-19320PUT0 0501.43TRUE00
2025-09-19350PUT0 0542.17TRUE00
2025-10-1780CALL0 0164.41TRUE00
2025-10-1790CALL0 0138.91TRUE00
2025-10-17100CALL0 0107.98TRUE00
2025-10-17115.9CALL0 595.05TRUE00
2025-10-17120CALL0 081.08TRUE00
2025-10-17132.55CALL64 1056.94TRUE2.550
2025-10-17141.71CALL33 850.59TRUE1.710
2025-10-17150.95CALL36 742.52TRUE0.950
2025-10-17160.53CALL9 4843.96FALSE-0.39-0.42
2025-10-17170.22CALL174 13546.76FALSE-0.33-0.6
2025-10-17180.16CALL47 11748.4FALSE-0.07-0.3
2025-10-17190.08CALL22 4249.32FALSE-0.02-0.2
2025-10-17200.09CALL1 24159.49FALSE0.020.29
2025-10-17210.3CALL0 12100.6FALSE00
2025-10-17220.22CALL0 4222FALSE00
2025-10-17230.14CALL0 5145.86FALSE00
2025-10-17240CALL0 0242.01FALSE00
2025-10-17250CALL0 0206.29FALSE00
2025-10-17300CALL0 0286.03FALSE00
2025-10-17350CALL0 0300.4FALSE00
2025-10-1780PUT0 0375.3FALSE00
2025-10-1790PUT0 0346.25FALSE00
2025-10-17100PUT0 0302.38FALSE00
2025-10-17110PUT0 0150.61FALSE00
2025-10-17120.07PUT50 056.43FALSE0.070
2025-10-17130.08PUT0 5056.7FALSE00
2025-10-17140.28PUT61 1244.87FALSE0.280
2025-10-17150.65PUT266 83645.51FALSE0.20.44
2025-10-17161.2PUT15 42445.25TRUE1.20
2025-10-17171.62PUT4 3443.24TRUE0.120.08
2025-10-17182.2PUT0 3430.05TRUE00
2025-10-17192.9PUT0 1260.44TRUE00
2025-10-17200PUT0 045.56TRUE00
2025-10-17210PUT0 075.99TRUE00
2025-10-17220PUT0 0106.19TRUE00
2025-10-17230PUT0 0104.43TRUE00
2025-10-17240PUT0 0136.28TRUE00
2025-10-17250PUT0 0124.94TRUE00
2025-10-17300PUT0 0167.57TRUE00
2025-10-17350PUT0 0193.53TRUE00
2025-11-21511.6CALL0 3224.38TRUE00
2025-11-21100CALL0 081.77TRUE00
2025-11-21118.46CALL0 286.4TRUE00
2025-11-21124.5CALL5 40TRUE4.50
2025-11-21135.3CALL0 1064.06TRUE00
2025-11-21142.73CALL5 2261.07TRUE2.730
2025-11-21152.57CALL0 3159.59TRUE00
2025-11-21161.33CALL10 27357.23FALSE-0.32-0.19
2025-11-21170.94CALL18 17958.53FALSE-0.21-0.18
2025-11-21180.62CALL36 12456.05FALSE-0.11-0.15
2025-11-21190.58CALL19 618363.28FALSE0.580
2025-11-21200.4CALL0 118456.32FALSE00
2025-11-21210.23CALL21 403958.24FALSE-0.1-0.3
2025-11-21220.3CALL0 410057.55FALSE00
2025-11-21230.16CALL20 11860.19FALSE0.160
2025-11-21240.1CALL0 182872.13FALSE00
2025-11-21250.1CALL0 161769.3FALSE00
2025-11-21260.2CALL0 280160.39FALSE00
2025-11-21270.25CALL0 122132.15FALSE00
2025-11-21280.12CALL0 106170.93FALSE00
2025-11-21290.35CALL0 43175.79FALSE00
2025-11-21300.1CALL0 32199.16FALSE00
2025-11-21310.5CALL0 20171.58FALSE00
2025-11-21320.2CALL0 48191.16FALSE00
2025-11-21330CALL0 0212.03FALSE00
2025-11-21340CALL0 3207.61FALSE00
2025-11-21350.04CALL0 38799.39FALSE00
2025-11-21360CALL0 6206.32FALSE00
2025-11-21370CALL0 0226.83FALSE00
2025-11-21380CALL0 0230.19FALSE00
2025-11-2150.05PUT0 10396.22FALSE00
2025-11-21100.17PUT0 373.55FALSE00
2025-11-21110.25PUT0 774.01FALSE00
2025-11-21120.1PUT0 3575.71FALSE00
2025-11-21130.52PUT19 225258.5FALSE0.520
2025-11-21140.89PUT35 258359.7FALSE0.890
2025-11-21151.34PUT189 254159.52FALSE1.340
2025-11-21161.67PUT2 130456.72TRUE1.670
2025-11-21172.04PUT0 22358.49TRUE00
2025-11-21182.47PUT0 18655.75TRUE00
2025-11-21192.87PUT0 13657.6TRUE00
2025-11-21203.8PUT0 7756.76TRUE00
2025-11-21214.35PUT0 6855.96TRUE00
2025-11-21225.97PUT0 1830TRUE00
2025-11-21235.9PUT0 1610TRUE00
2025-11-21244.1PUT0 5684.91TRUE00
2025-11-21250PUT0 2793.67TRUE00
2025-11-21269.2PUT0 287.1TRUE00
2025-11-212710.3PUT0 0106.98TRUE00
2025-11-21287.4PUT0 0114.89TRUE00
2025-11-21290PUT0 0108.77TRUE00
2025-11-21300PUT0 0112.9TRUE00
2025-11-21310PUT0 0107.97TRUE00
2025-11-21320PUT0 0120.65TRUE00
2025-11-21330PUT0 0138.82TRUE00
2025-11-21340PUT0 0131.85TRUE00
2025-11-21350PUT0 0135.29TRUE00
2025-11-21360PUT0 0138.61TRUE00
2025-11-21370PUT0 0128.18TRUE00
2025-11-21380PUT0 0136.22TRUE00
2026-01-1630CALL0 2148.59TRUE00
2026-01-1650CALL0 82110.04TRUE00
2026-01-1680CALL0 881.89TRUE00
2026-01-16105.7CALL1 3764.05TRUE5.70
2026-01-16124.9CALL0 3160.55TRUE00
2026-01-16134.3CALL0 3157.34TRUE00
2026-01-16145.69CALL0 256.27TRUE00
2026-01-16152.07CALL37 231655.11TRUE-0.43-0.17
2026-01-16161.65CALL36 7252.47FALSE-0.4-0.2
2026-01-16171.85CALL0 15754.8FALSE00
2026-01-16181.03CALL4 90853.21FALSE1.030
2026-01-16190.77CALL27 241652.3FALSE0.770
2026-01-16200.6CALL121 661752.67FALSE-0.23-0.28
2026-01-16210.57CALL26 44553.34FALSE0.070.14
2026-01-16220.39CALL78 75254.55FALSE-0.06-0.13
2026-01-16230.35CALL0 11557.02FALSE00
2026-01-16240.22CALL85 14653.96FALSE0.220
2026-01-16250.17CALL3 165254.14FALSE0.170
2026-01-16260.55CALL0 13073.17FALSE00
2026-01-16270.1CALL0 49171.58FALSE00
2026-01-16280.1CALL0 42117.61FALSE00
2026-01-16291.05CALL0 20129.14FALSE00
2026-01-16300.2CALL0 7835100.32FALSE00
2026-01-16310.37CALL0 55135.81FALSE00
2026-01-16320.4CALL0 9138.92FALSE00
2026-01-16330.17CALL0 48141.89FALSE00
2026-01-16340CALL0 1144.74FALSE00
2026-01-16350.1CALL0 354693.09FALSE00
2026-01-16360CALL0 0164.28FALSE00
2026-01-16370CALL0 0157.47FALSE00
2026-01-16380.05CALL0 1684169.34FALSE00
2026-01-1630PUT0 0516.68FALSE00
2026-01-1650PUT0 0320.83FALSE00
2026-01-1680PUT0 18137.04FALSE00
2026-01-16100PUT0 566.47FALSE00
2026-01-16120.39PUT0 1155.53FALSE00
2026-01-16130.85PUT2 110556.28FALSE0.150.21
2026-01-16141.17PUT1 12753.91FALSE1.170
2026-01-16151.4PUT0 90452.6FALSE00
2026-01-16161.8PUT0 5958.02TRUE00
2026-01-16172.29PUT0 18651.96TRUE00
2026-01-16183.2PUT0 2650.88TRUE00
2026-01-16193.2PUT0 5173.44TRUE00
2026-01-16204.6PUT0 425950.76TRUE00
2026-01-16213.45PUT0 6749.74TRUE00
2026-01-16227PUT0 10348.95TRUE00
2026-01-16236.5PUT0 653.27TRUE00
2026-01-16248.8PUT0 7357.34TRUE00
2026-01-16255.55PUT0 9079.24TRUE00
2026-01-162610PUT0 500TRUE00
2026-01-16270PUT0 3763.96TRUE00
2026-01-16280PUT0 00TRUE00
2026-01-16290PUT0 00TRUE00
2026-01-16300PUT0 00TRUE00
2026-01-16310PUT0 00TRUE00
2026-01-16320PUT0 083.61TRUE00
2026-01-16330PUT0 086.33TRUE00
2026-01-16340PUT0 00TRUE00
2026-01-16350PUT0 10TRUE00
2026-01-16360PUT0 088.88TRUE00
2026-01-16370PUT0 00TRUE00
2026-01-16380PUT0 00TRUE00
2026-02-2050CALL0 0142.4TRUE00
2026-02-20106.72CALL0 363.51TRUE00
2026-02-20117CALL0 1059.35TRUE00
2026-02-20120CALL0 058.69TRUE00
2026-02-20130CALL0 052.75TRUE00
2026-02-20142.7CALL3 053TRUE2.70
2026-02-20153.3CALL0 353.73TRUE00
2026-02-20161.85CALL1 1050.67FALSE1.850
2026-02-20171.8CALL0 5452.82FALSE00
2026-02-20181.62CALL0 6950.89FALSE00
2026-02-20191.35CALL0 11550.72FALSE00
2026-02-20201.05CALL0 2749.89FALSE00
2026-02-20210.8CALL0 15052.49FALSE00
2026-02-20220.92CALL0 1153.61FALSE00
2026-02-20231.04CALL0 053.97FALSE00
2026-02-20240CALL0 055.62FALSE00
2026-02-20250.45CALL0 50071.91FALSE00
2026-02-20260.35CALL0 173.63FALSE00
2026-02-20270CALL0 076.83FALSE00
2026-02-20300CALL0 0130.12FALSE00
2026-02-20350.2CALL0 8129.8FALSE00
2026-02-2050PUT0 0283.91FALSE00
2026-02-20100.21PUT0 581.79FALSE00
2026-02-20110PUT0 088.55FALSE00
2026-02-20120PUT0 054.21FALSE00
2026-02-20130.75PUT0 150.94FALSE00
2026-02-20140.8PUT0 752.45FALSE00
2026-02-20151.53PUT0 1152.86FALSE00
2026-02-20161.95PUT0 1048.8TRUE00
2026-02-20170PUT0 047.95TRUE00
2026-02-20182.95PUT0 247.2TRUE00
2026-02-20193.2PUT0 149.62TRUE00
2026-02-20204.7PUT0 352.48TRUE00
2026-02-20210PUT0 051.05TRUE00
2026-02-20220PUT0 053.82TRUE00
2026-02-20230PUT0 056.03TRUE00
2026-02-20248.1PUT0 555.26TRUE00
2026-02-20250PUT0 061.37TRUE00
2026-02-20260PUT0 062.22TRUE00
2026-02-20270PUT0 074.84TRUE00
2026-02-20300PUT0 084.16TRUE00
2026-02-20350PUT0 083.56TRUE00
2026-03-2050CALL0 083.35TRUE00
2026-03-20100CALL0 055.08TRUE00
2026-03-20110CALL0 060.12TRUE00
2026-03-20120CALL0 060.98TRUE00
2026-03-20130CALL0 062.46TRUE00
2026-03-20140CALL0 055.55TRUE00
2026-03-20152.75CALL2 357.6TRUE2.750
2026-03-20162.7CALL0 3053.94FALSE00
2026-03-20171.8CALL100 953.61FALSE-0.26-0.13
2026-03-20181.83CALL0 5453.16FALSE00
2026-03-20191.2CALL8 152.72FALSE1.20
2026-03-20202.05CALL0 3051.78FALSE00
2026-03-20210.93CALL0 151.07FALSE00
2026-03-20220.77CALL0 8850.81FALSE00
2026-03-20230.75CALL0 1256.13FALSE00
2026-03-20240.48CALL0 1250.16FALSE00
2026-03-20250.38CALL0 856.11FALSE00
2026-03-20270.68CALL0 773.85FALSE00
2026-03-20300CALL0 089.63FALSE00
2026-03-20350CALL0 0119.49FALSE00
2026-03-2050PUT0 0262.04FALSE00
2026-03-20100PUT0 077.64FALSE00
2026-03-20110PUT0 071.44FALSE00
2026-03-20120PUT0 075.66FALSE00
2026-03-20131.35PUT0 652.24FALSE00
2026-03-20141.5PUT0 254.99FALSE00
2026-03-20151.5PUT0 853.77FALSE00
2026-03-20161.77PUT0 151.65TRUE00
2026-03-20170PUT0 049.21TRUE00
2026-03-20183.8PUT1 451.17TRUE3.80
2026-03-20190PUT0 048.79TRUE00
2026-03-20200PUT0 050.27TRUE00
2026-03-20210PUT0 055.18TRUE00
2026-03-20220PUT0 051.94TRUE00
2026-03-20230PUT0 050.32TRUE00
2026-03-20240PUT0 049.12TRUE00
2026-03-20250PUT0 049.13TRUE00
2026-03-20270PUT0 065.82TRUE00
2026-03-20300PUT0 00TRUE00
2026-03-20350PUT0 00TRUE00
2026-04-1750CALL0 00TRUE00
2026-04-17106.08CALL1 1163.23TRUE6.080
2026-04-17110CALL0 058.82TRUE00
2026-04-17120CALL0 063.59TRUE00
2026-04-17130CALL0 054.37TRUE00
2026-04-17144.37CALL0 153.68TRUE00
2026-04-17153.38CALL0 151.57TRUE00
2026-04-17160CALL0 052.05FALSE00
2026-04-17172.05CALL11 136.73FALSE2.050
2026-04-17182.25CALL0 2150.87FALSE00
2026-04-17190CALL0 049.98FALSE00
2026-04-17201.6CALL0 549.2FALSE00
2026-04-17210CALL0 051.18FALSE00
2026-04-17220.79CALL5 3352.35FALSE0.790
2026-04-17230CALL0 053.52FALSE00
2026-04-17241.3CALL0 653.92FALSE00
2026-04-17250.47CALL0 1159.98FALSE00
2026-04-17270CALL0 072.84FALSE00
2026-04-17300CALL0 074.69FALSE00
2026-04-17350CALL0 0112.41FALSE00
2026-04-1750PUT0 0177.2FALSE00
2026-04-17100PUT0 060.53FALSE00
2026-04-17110.46PUT0 153.82FALSE00
2026-04-17120.69PUT0 154.09FALSE00
2026-04-17131.09PUT0 667.34FALSE00
2026-04-17141.25PUT0 152.84FALSE00
2026-04-17152.05PUT5 3751.11FALSE2.050
2026-04-17160PUT0 052.4TRUE00
2026-04-17170PUT0 042.6TRUE00
2026-04-17183.6PUT0 347.18TRUE00
2026-04-17193.8PUT0 148.5TRUE00
2026-04-17204.3PUT0 450.11TRUE00
2026-04-17210PUT0 050.87TRUE00
2026-04-17220PUT0 053.71TRUE00
2026-04-17230PUT0 054.67TRUE00
2026-04-17240PUT0 051.3TRUE00
2026-04-17250PUT0 00TRUE00
2026-04-17270PUT0 062.53TRUE00
2026-04-17300PUT0 063.42TRUE00
2026-04-17350PUT0 070.95TRUE00
2026-06-1850CALL0 078.39TRUE00
2026-06-18100CALL0 048.53TRUE00
2026-06-18135.6CALL0 557.2TRUE00
2026-06-18153.58CALL0 12652.48TRUE00
2026-06-18181.9CALL309 63250.8FALSE1.90
2026-06-18201.4CALL3 36350.9FALSE1.40
2026-06-18222CALL0 19150.34FALSE00
2026-06-18251.4CALL0 453.65FALSE00
2026-06-18270.77CALL0 40149.42FALSE00
2026-06-18300.69CALL0 368FALSE00
2026-06-18350.05CALL0 695.32FALSE00
2026-06-1850PUT0 0219.76FALSE00
2026-06-18100PUT0 064.56FALSE00
2026-06-18131.45PUT1 053.15FALSE1.450
2026-06-18152.25PUT1 549.78FALSE2.250
2026-06-18183.9PUT0 252.32TRUE00
2026-06-18204.43PUT0 3247.61TRUE00
2026-06-18220PUT0 053.59TRUE00
2026-06-18250PUT0 049.96TRUE00
2026-06-18270PUT0 048.63TRUE00
2026-06-18300PUT0 055.56TRUE00
2026-06-18350PUT0 065.48TRUE00
2027-01-15314.95CALL0 190TRUE00
2027-01-15511.91CALL0 769.6TRUE00
2027-01-1589.2CALL0 655.42TRUE00
2027-01-15108.71CALL0 40157.23TRUE00
2027-01-15135.46CALL0 4254.26TRUE00
2027-01-15154.21CALL2 50954.92TRUE-0.2-0.05
2027-01-15173.35CALL8 27750.73FALSE-0.15-0.04
2027-01-15202.2CALL71 89048.61FALSE2.20
2027-01-15221.97CALL1 37847.92FALSE1.970
2027-01-15251.27CALL0 69549.63FALSE00
2027-01-15271.05CALL0 339046.05FALSE00
2027-01-15300.6CALL5 55245.13FALSE0.60
2027-01-15320.71CALL0 2164.85FALSE00
2027-01-15350.3CALL10 17043.83FALSE0.30
2027-01-15370.3CALL0 763.73FALSE00
2027-01-1530PUT0 0229.98FALSE00
2027-01-1550PUT0 582.11FALSE00
2027-01-1580.48PUT4 1355.54FALSE00
2027-01-15100.4PUT0 4465.09FALSE00
2027-01-15130PUT0 102449.44FALSE00
2027-01-15152.77PUT0 13049.58FALSE00
2027-01-15174.13PUT1 9649.61TRUE4.130
2027-01-15205.3PUT0 4147.06TRUE00
2027-01-15227.5PUT3 19445.26TRUE0.30.04
2027-01-15258.15PUT0 4445.01TRUE00
2027-01-15270PUT0 354.69TRUE00
2027-01-15300PUT0 00TRUE00
2027-01-15320PUT0 050.04TRUE00
2027-01-15350PUT0 00TRUE00
2027-01-153717.31PUT0 00TRUE00
2028-01-2130CALL0 080.09TRUE00
2028-01-2150CALL0 058.79TRUE00
2028-01-2180CALL0 058.75TRUE00
2028-01-21100CALL0 051.32TRUE00
2028-01-21130CALL0 050.86TRUE00
2028-01-21155.4CALL2 053.29TRUE5.40
2028-01-21174.8CALL3 054FALSE4.80
2028-01-21203.53CALL2 049.04FALSE3.530
2028-01-21220CALL0 048.23FALSE00
2028-01-21250CALL0 046.67FALSE00
2028-01-21270CALL0 068.32FALSE00
2028-01-21303CALL20 062.02FALSE30
2028-01-2130PUT0 096.53FALSE00
2028-01-2150PUT0 077.82FALSE00
2028-01-2180PUT0 094.38FALSE00
2028-01-21100PUT0 0116.62FALSE00
2028-01-21130PUT0 051.11FALSE00
2028-01-21150PUT0 050.54FALSE00
2028-01-21170PUT0 049.94TRUE00
2028-01-21200PUT0 049.33TRUE00
2028-01-21220PUT0 049.43TRUE00
2028-01-21250PUT0 044.56TRUE00
2028-01-21270PUT0 048.51TRUE00
2028-01-21300PUT0 046.07TRUE00

Latest ADMA Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST38$1.905
Jun 13, 2022 7:59 PM EST100$1.905
Jun 13, 2022 7:59 PM EST100$1.905
Jun 13, 2022 7:59 PM EST36$1.905
Jun 13, 2022 7:59 PM EST100$1.9

ADMA Biologics, Inc (ADMA) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000713/0001193805-20-000713-index.htm
2019-10-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1368514/000000000019014431/0000000000-19-014431-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000083423720008032/0000834237-20-008032-index.htm
2020-03-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000083423720009209/0000834237-20-009209-index.htm
2019-05-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000089924319014466/0000899243-19-014466-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000089924320003914/0000899243-20-003914-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000089924320009225/0000899243-20-009225-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000091957419001192/0000919574-19-001192-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000091957420001141/0000919574-20-001141-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000108514619000734/0001085146-19-000734-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000108514620000752/0001085146-20-000752-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000112329219000868/0001123292-19-000868-index.htm
2019-06-07SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1368514/000112329219000869/0001123292-19-000869-index.htm
2020-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000114036120010160/0001140361-20-010160-index.htm
2020-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1368514/000114036120010161/0001140361-20-010161-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000119312519040961/0001193125-19-040961-index.htm
2019-05-23SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000119312519154707/0001193125-19-154707-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1368514/000119312520038101/0001193125-20-038101-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001175/0001193805-18-001175-index.htm
2018-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001198/0001193805-18-001198-index.htm
2018-10-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001210/0001193805-18-001210-index.htm
2018-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001238/0001193805-18-001238-index.htm
2018-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001316/0001193805-18-001316-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380518001319/0001193805-18-001319-index.htm
2018-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001425/0001193805-18-001425-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001429/0001193805-18-001429-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380518001431/0001193805-18-001431-index.htm
2019-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000012/0001193805-19-000012-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000026/0001193805-19-000026-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000090/0001193805-19-000090-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000091/0001193805-19-000091-index.htm
2019-01-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000092/0001193805-19-000092-index.htm
2019-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000098/0001193805-19-000098-index.htm
2019-02-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000160/0001193805-19-000160-index.htm
2019-02-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000246/0001193805-19-000246-index.htm
2019-02-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000251/0001193805-19-000251-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000254/0001193805-19-000254-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000280/0001193805-19-000280-index.htm
2019-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000281/0001193805-19-000281-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000292/0001193805-19-000292-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000293/0001193805-19-000293-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000294/0001193805-19-000294-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000295/0001193805-19-000295-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000296/0001193805-19-000296-index.htm
2019-03-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000297/0001193805-19-000297-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000301/0001193805-19-000301-index.htm
2019-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000332/0001193805-19-000332-index.htm
2019-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000339/0001193805-19-000339-index.htm
2019-04-05PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000346/0001193805-19-000346-index.htm
2019-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000366/0001193805-19-000366-index.htm
2019-04-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000415/0001193805-19-000415-index.htm
2019-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000441/0001193805-19-000441-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000454/0001193805-19-000454-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000455/0001193805-19-000455-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000470/0001193805-19-000470-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000490/0001193805-19-000490-index.htm
2019-05-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000492/0001193805-19-000492-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000496/0001193805-19-000496-index.htm
2019-05-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000498/0001193805-19-000498-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000521/0001193805-19-000521-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000522/0001193805-19-000522-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000523/0001193805-19-000523-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000524/0001193805-19-000524-index.htm
2019-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000525/0001193805-19-000525-index.htm
2019-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000540/0001193805-19-000540-index.htm
2019-06-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000559/0001193805-19-000559-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000561/0001193805-19-000561-index.htm
2019-06-128-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000569/0001193805-19-000569-index.htm
2019-07-01PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000614/0001193805-19-000614-index.htm
2019-07-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000621/0001193805-19-000621-index.htm
2019-07-16DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000637/0001193805-19-000637-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000714/0001193805-19-000714-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000715/0001193805-19-000715-index.htm
2019-08-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000761/0001193805-19-000761-index.htm
2019-08-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000774/0001193805-19-000774-index.htm
2019-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000798/0001193805-19-000798-index.htm
2019-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000839/0001193805-19-000839-index.htm
2019-10-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000887/0001193805-19-000887-index.htm
2019-10-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000893/0001193805-19-000893-index.htm
2019-10-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1368514/000119380519000903/0001193805-19-000903-index.htm
2019-10-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519000905/0001193805-19-000905-index.htm
2019-10-07424B7Prospectus [Rule 424(b)(7)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519000907/0001193805-19-000907-index.htm
2019-10-10CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001327/0001193805-19-001327-index.htm
2019-10-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001351/0001193805-19-001351-index.htm
2019-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001355/0001193805-19-001355-index.htm
2019-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001361/0001193805-19-001361-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001396/0001193805-19-001396-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380519001398/0001193805-19-001398-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001423/0001193805-19-001423-index.htm
2019-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001461/0001193805-19-001461-index.htm
2019-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380519001941/0001193805-19-001941-index.htm
2020-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000010/0001193805-20-000010-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000024/0001193805-20-000024-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000033/0001193805-20-000033-index.htm
2020-02-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000106/0001193805-20-000106-index.htm
2020-02-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000109/0001193805-20-000109-index.htm
2020-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000110/0001193805-20-000110-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000129/0001193805-20-000129-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000133/0001193805-20-000133-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000135/0001193805-20-000135-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000138/0001193805-20-000138-index.htm
2020-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000139/0001193805-20-000139-index.htm
2020-02-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000259/0001193805-20-000259-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000285/0001193805-20-000285-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000286/0001193805-20-000286-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000287/0001193805-20-000287-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000288/0001193805-20-000288-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000289/0001193805-20-000289-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000290/0001193805-20-000290-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000291/0001193805-20-000291-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000292/0001193805-20-000292-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000293/0001193805-20-000293-index.htm
2020-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000300/0001193805-20-000300-index.htm
2020-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000348/0001193805-20-000348-index.htm
2020-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000349/0001193805-20-000349-index.htm
2020-03-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000377/0001193805-20-000377-index.htm
2020-04-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000452/0001193805-20-000452-index.htm
2020-04-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000474/0001193805-20-000474-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000502/0001193805-20-000502-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000529/0001193805-20-000529-index.htm
2020-05-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000548/0001193805-20-000548-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000549/0001193805-20-000549-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000550/0001193805-20-000550-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000551/0001193805-20-000551-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000552/0001193805-20-000552-index.htm
2020-05-014/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000553/0001193805-20-000553-index.htm
2020-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000561/0001193805-20-000561-index.htm
2020-05-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000562/0001193805-20-000562-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000618/0001193805-20-000618-index.htm
2020-05-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000638/0001193805-20-000638-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000710/0001193805-20-000710-index.htm
2020-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000712/0001193805-20-000712-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000713/0001193805-20-000713-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000770/0001193805-20-000770-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520000957/0001193805-20-000957-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000960/0001193805-20-000960-index.htm
2020-08-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520000961/0001193805-20-000961-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001004/0001193805-20-001004-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001036/0001193805-20-001036-index.htm
2020-08-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001111/0001193805-20-001111-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001128/0001193805-20-001128-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001129/0001193805-20-001129-index.htm
2020-09-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001135/0001193805-20-001135-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001139/0001193805-20-001139-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1368514/000119380520001390/0001193805-20-001390-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520001392/0001193805-20-001392-index.htm
2020-11-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1368514/000119380520001393/0001193805-20-001393-index.htm
2019-10-15EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1368514/999999999519002318/9999999995-19-002318-index.htm
2018-09-24CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1368514/999999999718008174/9999999997-18-008174-index.htm
2019-04-16CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1368514/999999999719002962/9999999997-19-002962-index.htm
2020-02-03SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1368514/999999999720000431/9999999997-20-000431-index.htm
2020-02-10SEC STAFF SEC Staff Letter: REDACTED EXHIBIThttps://www.sec.gov/Archives/edgar/data/1368514/999999999720000623/9999999997-20-000623-index.htm

ADMA Biologics, Inc (ADMA) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ADMA Biologics, Inc (ADMA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 213%
Institutional Ownership: 5451%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-05-17Jerrold B GrossmanDirectorBuy12,000.004.0048,000.00110,007.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000524/0001193805-19-000524-index.htm
2019-05-21PERCEPTIVE ADVISORS LLC10% Share HolderBuy4,000,000.004.0016,000,000.0011,521,102.00https://www.sec.gov/Archives/edgar/data/1368514/000089924319014466/0000899243-19-014466-index.htm
2020-02-11Jerrold B GrossmanDirectorBuy22,857.003.5079,999.50132,864.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2020-02-28Jerrold B GrossmanDirectorBuy7,500.00140,364.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000288/0001193805-20-000288-index.htm
2020-08-12Jerrold B GrossmanDirectorBuy200.002.87574.00140,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-12Jerrold B GrossmanDirectorBuy5,000.002.8914,450.00145,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-12Jerrold B GrossmanDirectorBuy5,000.002.9014,475.00150,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm
2020-08-21Jerrold B GrossmanDirectorBuy5,000.002.5612,800.00155,564.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-08-21Jerrold B GrossmanDirectorBuy300.002.62786.00155,864.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm
2020-02-11PERCEPTIVE ADVISORS LLC10% Share HolderBuy4,563,700.003.5015,972,950.0016,084,802.00https://www.sec.gov/Archives/edgar/data/1368514/000089924320003914/0000899243-20-003914-index.htm
2020-09-10Jerrold B GrossmanDirectorBuy5,000.002.2211,100.00160,864.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001135/0001193805-20-001135-index.htm
2020-03-19PERCEPTIVE ADVISORS LLC10% Share HolderBuy500,000.002.101,050,000.0016,584,802.00https://www.sec.gov/Archives/edgar/data/1368514/000089924320009225/0000899243-20-009225-index.htm
2020-02-28Adam S GrossmanPresident and CEOBuy100,000.00166,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000287/0001193805-20-000287-index.htm
2020-08-10Adam S GrossmanPresident and CEOBuy10.003.0630.60166,108.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-10Adam S GrossmanPresident and CEOBuy2,990.003.079,179.30169,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-10Adam S GrossmanPresident and CEOBuy2,000.003.046,080.00171,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-08-11Adam S GrossmanPresident and CEOBuy1,000.002.972,970.00172,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm
2020-09-08Adam S GrossmanPresident and CEOBuy4,000.002.248,959.60176,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001128/0001193805-20-001128-index.htm
2019-05-17James MondEVP, CSO and CMOBuy4,500.004.0018,000.0017,889.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000522/0001193805-19-000522-index.htm
2020-08-13MARTHA J DEMSKIDirectorBuy2,000.002.885,760.002,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001036/0001193805-20-001036-index.htm
2020-02-11James MondCSO and CMOBuy4,285.003.5014,997.5022,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000133/0001193805-20-000133-index.htm
2020-02-11Jerrold B GrossmanDirectorBuy22,857.003.5079,999.5022,857.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm
2019-05-17BRIAN LENZEVP, CFOBuy5,000.004.0020,000.0025,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000521/0001193805-19-000521-index.htm
2020-02-11BRIAN LENZEVP, CFOBuy7,142.003.5024,997.0032,142.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000129/0001193805-20-000129-index.htm
2019-05-17Adam S GrossmanPresident and CEOBuy5,000.004.0020,000.0037,527.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2020-09-11MARTHA J DEMSKIDirectorBuy2,200.002.295,038.004,200.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001139/0001193805-20-001139-index.htm
2019-06-06Biotest Divestiture Trust10% Share HolderSell5,813,954.003.7521,802,327.504,295,580.00https://www.sec.gov/Archives/edgar/data/1368514/000112329219000868/0001123292-19-000868-index.htm
2020-02-28ERIC I RICHMANDirectorBuy7,500.0044,030.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000290/0001193805-20-000290-index.htm
2019-05-17Lawrence P. GuiheenDirectorBuy25,000.004.00100,000.0050,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000523/0001193805-19-000523-index.htm
2020-02-28James MondEVP, CSO and CMOBuy40,000.0062,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000285/0001193805-20-000285-index.htm
2020-02-11Adam S GrossmanPresident and CEOBuy28,571.003.5099,998.5066,098.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm
2020-08-10James MondEVP, CSO and CMOBuy5,000.002.8814,400.0067,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-08-10James MondEVP, CSO and CMOBuy2,000.002.885,750.0069,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm
2020-02-11Lawrence P. GuiheenDirectorBuy20,000.003.5070,000.0070,000.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000135/0001193805-20-000135-index.htm
2020-02-28BRIAN LENZEVP, CFOBuy40,000.0072,142.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000286/0001193805-20-000286-index.htm
2020-09-08James MondEVP, CSO and CMOBuy4,000.002.208,800.0073,174.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001129/0001193805-20-001129-index.htm
2020-02-28Bryant FongDirectorBuy7,500.007,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000293/0001193805-20-000293-index.htm
2020-02-28DOV A MD GOLDSTEINDirectorBuy7,500.007,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000291/0001193805-20-000291-index.htm
2020-02-28STEVE ELMSDirectorBuy7,500.007,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000292/0001193805-20-000292-index.htm
2020-08-11BRIAN LENZEVP, CFOBuy4,000.002.9711,860.0076,142.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520001004/0001193805-20-001004-index.htm
2020-02-28Lawrence P. GuiheenDirectorBuy7,500.0077,500.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000289/0001193805-20-000289-index.htm
2019-05-17Adam S GrossmanPresident and CEOBuy25,000.004.00100,000.00821,301.00https://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm
2020-02-11Adam S GrossmanPresident and CEOBuy57,143.003.50200,000.50878,444.00https://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm